We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Top Sells

Rank Stock Value
1
PHLT
Performant Healthcare Inc
PHLT
+$5.84M
2
ANAB icon
AnaptysBio
ANAB
+$1.6M
3
INSM icon
Insmed
INSM
+$1M
4
ATEC icon
Alphatec Holdings
ATEC
+$740K
5
WFC icon
Wells Fargo
WFC
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEVO icon
401
Gevo
GEVO
$372M
$5K ﹤0.01%
2,500
– –
ING icon
402
ING
ING
$99.8B
$5K ﹤0.01%
179
– –
AA icon
403
Alcoa
AA
$11.9B
$5K ﹤0.01%
94
-38
-29% -$1.55K
SNDL icon
404
Sundial Growers
SNDL
$325M
$4.98K ﹤0.01%
3,000
– –
FSTA icon
405
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$4.92K ﹤0.01%
100
– –
PYPL icon
406
PayPal
PYPL
$49.3B
$4.9K ﹤0.01%
84
+59
+236% +$3.83K
JPM icon
407
JPMorgan Chase
JPM
$933B
$4.87K ﹤0.01%
15
+14
+1,400% +$4.33K
TMDX icon
408
Transmedics
TMDX
$2.63B
$4.87K ﹤0.01%
40
– –
SAP icon
409
SAP
SAP
$209B
$4.86K ﹤0.01%
20
– –
COF icon
410
Capital One
COF
$129B
$4.85K ﹤0.01%
20
– –
OCUL icon
411
Ocular Therapeutix
OCUL
$1.85B
$4.82K ﹤0.01%
397
– –
GLW icon
412
Corning
GLW
$116B
$4.82K ﹤0.01%
55
-20
-27% -$1.72K
ARKF icon
413
ARK Blockchain & Fintech Innovation ETF
ARKF
$737M
$4.77K ﹤0.01%
100
– –
VLUE icon
414
iShares MSCI USA Value Factor ETF
VLUE
$9.28B
$4.73K ﹤0.01%
35
-2
-5% -$262
VFH icon
415
Vanguard Financials ETF
VFH
$13.5B
$4.71K ﹤0.01%
35
– –
XNCR icon
416
Xencor
XNCR
$1.59B
$4.59K ﹤0.01%
300
– –
OMCL icon
417
Omnicell
OMCL
$1.69B
$4.53K ﹤0.01%
100
– –
GRWG icon
418
GrowGeneration
GRWG
$87.1M
$4.5K ﹤0.01%
3,000
– –
IONQ icon
419
IonQ
IONQ
$13.4B
$4.49K ﹤0.01%
100
+42
+72% +$2.35K
BMRN icon
420
BioMarin Pharmaceuticals
BMRN
$11.7B
$4.46K ﹤0.01%
75
– –
ELF icon
421
e.l.f. Beauty
ELF
$4.85B
$4.44K ﹤0.01%
58
– –
AVY icon
422
Avery Dennison
AVY
$13.4B
$4.37K ﹤0.01%
24
+8
+50% +$1.38K
DUK icon
423
Duke Energy
DUK
$98.4B
$4.34K ﹤0.01%
37
– –
SRLN icon
424
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$4.33K ﹤0.01%
+105
New +$4.33K
ASML icon
425
ASML
ASML
$634B
$4.28K ﹤0.01%
4
– –
15 16
17
18 19

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
SVWG
Shared Vision Wealth Group Carlsbad, United States $245M AUM 15.52% 1-Year Est. Return

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.